Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)

Lynn Symonds, Ming Yu, Yu Hong Zhang, Fang Shu Ou, Tyler J. Zemla, Kelly Carter, Monica Bertagnolli, Federico Innocenti, Linda J.W. Bosch, Gerrit A. Meijer, Beatriz Carvalho, William M. Grady, Stacey A. Cohen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)'. Together they form a unique fingerprint.

Medicine & Life Sciences